We are live on ! Find out more
OCM

Ovata Capital Management Portfolio holdings

AUM $1.33B
1-Year Est. Return 5.69%
This Fund
S&P 500
This Quarter Est. Return
+17.46%
1 Year Est. Return
+5.69%
3 Year Est. Return
+69.09%
5 Year Est. Return
+58.06%
10 Year Est. Return
AUM
$281M
AUM Growth
-$53.7M
Cap. Flow
-$144M
Cap. Flow %
-51.29%
Top 10 Hldgs %
67.82%
Holding
211
New
27
Increased
10
Reduced
12
Closed
140

Top Sells

Rank Stock Value
1
TNC icon
Tennant Co
TNC
+$47.6M
2
AMZN icon
Amazon
AMZN
+$13.8M
3
NTES icon
NetEase
NTES
+$12.8M
4
JD icon
JD.com
JD
+$11.8M
5
ATHM icon
Autohome
ATHM
+$10.2M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 38.32%
2 Financials 12.4%
3 Technology 7.07%
4 Industrials 4.64%
5 Communication Services 4.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VAR
26
DELISTED
Varian Medical Systems, Inc.
VAR
$1.58M 0.56%
9,215
+9,015
+4,508% +$1.42M
CNK icon
27
Cinemark Holdings
CNK
$4.32B
$1.57M 0.56%
123,252
-4,571
-4% -$57K
DOYU
28
DouYu International Holdings
DOYU
$142M
$1.43M 0.51%
+10,807
New +$1.55M
LX
29
LexinFintech Holdings
LX
$241M
$1.37M 0.49%
+200,000
New +$1.74M
CD
30
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
$1.14M 0.4%
+70,000
New +$1.14M
GLD icon
31
SPDR Gold Trust
GLD
$141B
$886K 0.32%
5,000
CETV
32
DELISTED
Central European Media Enterprises Ltd
CETV
$876K 0.31%
208,950
-360,470
-63% -$1.47M
BMY icon
33
Bristol-Myers Squibb
BMY
$132B
$689K 0.25%
306,302
+174,625
+133% +$10.5M
FRLN
34
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$585K 0.21%
+2,500
New +$627K
CSIQ icon
35
Canadian Solar
CSIQ
$1.08B
0
GNW icon
36
Genworth Financial
GNW
$3.71B
$466K 0.17%
+139,200
New +$371K
BTAI icon
37
BioXcel Therapeutics
BTAI
$27.8M
$434K 0.15%
+625
New +$469K
POOL icon
38
Pool Corp
POOL
$7.5B
$401K 0.14%
+1,200
New +$371K
IMMU
39
DELISTED
Immunomedics Inc
IMMU
$400K 0.14%
4,700
-2,180
-32% -$110K
BREW
40
DELISTED
Craft Brew Alliance, Inc.
BREW
$305K 0.11%
18,493
+8,237
+80% +$127K
CVNA icon
41
Carvana
CVNA
$77.9B
$268K 0.1%
+6,000
New +$213K
DKNG icon
42
DraftKings
DKNG
$11.9B
$247K 0.09%
+4,200
New +$163K
CHT icon
43
Chunghwa Telecom
CHT
$33B
$217K 0.08%
5,900
ETSY icon
44
Etsy
ETSY
$7.85B
$207K 0.07%
+1,700
New +$199K
ATXS
45
DELISTED
Astria Therapeutics
ATXS
$186K 0.07%
5,000
Z icon
46
Zillow
Z
$7.56B
$173K 0.06%
+1,700
New +$133K
VNRX icon
47
VolitionRx Ltd
VNRX
$9.34M
$161K 0.06%
2,500
NET icon
48
Cloudflare
NET
$107B
$158K 0.06%
+3,851
New +$147K
ASX icon
49
ASE Group
ASX
$82.2B
$140K 0.05%
34,293
HZNP
50
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$132K 0.05%
+1,700
New +$117K

Similar funds

Ovata Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Ovata Capital Management held 211 positions worth $281M, down 16% from $334M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Ovata Capital Management withdrew a net $144M in Q3 2020, closing 140 positions and reducing 12 holdings. Its most notable exit was Amazon, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 38% of assets, up from 29% a quarter earlier, followed by Financials and Technology.

Against the trend, Ovata Capital Management opened a new position in Maxim Integrated Products worth $8.99M.

  • Ovata Capital Management's largest Q3 2020 buy was Maxim Integrated Products: 133,004 shares worth $8.99M.
  • Ovata Capital Management added most to Bristol-Myers Squibb in Q3 2020, an estimated $10.5M increase.
  • Ovata Capital Management's biggest Q3 2020 reduction was Tennant Co, cutting an estimated $47.6M.
  • Ovata Capital Management fully exited Amazon in Q3 2020, selling an estimated $13.8M.
  • Ovata Capital Management's ten largest holdings make up 68% of its $281M portfolio in Q3 2020.
  • Ovata Capital Management opened 27 new positions and closed 140 in Q3 2020.
  • Ovata Capital Management's portfolio value fell 16% quarter-over-quarter to $281M.

Based on Ovata Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.